Mitchell J Geer

9PUBLICATIONS
52CO-AUTHORS
Haematological tumoursMolecular targetsMedical infection agents (incl. prions)HaematologyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 13, 2025
T Lymphocyte-Specific Deletion of SHP1 and SHP2 Promotes Activation-Induced Cell Death of CD4+ T Cells and Impairs Antitumor Response.

Connor J R Foster, Jasper Du, Oscar Pundel

|Feb 23, 2023
Genome-wide CRISPR/Cas9 screens reveal shared and cell-specific mechanisms of resistance to SHP2 inhibition.

Wei Wei, Mitchell J Geer, Xinyi Guo

|Oct 21, 2022
Treatment of congenital thrombocytopenia and decreased collagen reactivity in G6b-B-deficient mice.

Alexandra Mazharian, Blandine Maître, Alicia Bornert

|Jul 27, 2018
SHP2 Inhibition Prevents Adaptive Resistance to MEK Inhibitors in Multiple Cancer Models.

Carmine Fedele, Hao Ran, Brian Diskin

Pageof 2